Back
ProShares Ultra Financials Vs. Akero Therapeutics Industry Stock Comparison
Buy
70
UYG
ProShares Ultra Financials
Last Price:
$90.00
Seasonality Move:
0.21%
Buy
68
AKRO
Akero Therapeutics
Last Price:
$54.15
Seasonality Move:
26.74%
Buy
70
ProShares Ultra Financials (UYG)
is a Buy
Is ProShares Ultra Financials a Buy, Sell or Hold?
-
The current ProShares Ultra Financials [UYG] share price is $91.53. The Score for UYG is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
UYG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $54.28. The Score for AKRO is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
UYG Stock Price Chart
What is ProShares Ultra Financials's stock price today?
-
The ProShares Ultra Financials share price today is $91.53The current trend is moderately bullish and UYG is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $54.28Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
UYG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.35 | Buy |
| Relative Strength Index (14 RSI): | 58.79 | Buy |
| Chaikin Money Flow: | 5851 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (87.12 - 91.7) | Buy |
| Bollinger Bands (100): | (81.42 - 95.24) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.09 | Buy |
| Relative Strength Index (14 RSI): | 70.44 | Buy |
| Chaikin Money Flow: | -1219058 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.53 - 50.43) | Buy |
| Bollinger Bands (100): | (34.89 - 51.35) | Buy |
UYG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 90.16 | Buy |
| 20-day SMA: | 90.25 | Buy |
| 50-day SMA: | 84.72 | Buy |
| 200-day SMA: | 85.42 | Buy |
| 8-day EMA: | 90.23 | Buy |
| 20-day EMA: | 89.22 | Buy |
| 50-day EMA: | 87.49 | Buy |
| 200-day EMA: | 83.31 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.82 | Buy |
| 20-day SMA: | 46 | Buy |
| 50-day SMA: | 42.47 | Buy |
| 200-day SMA: | 36.08 | Buy |
| 8-day EMA: | 51.3 | Buy |
| 20-day EMA: | 47.76 | Buy |
| 50-day EMA: | 44.57 | Buy |
| 200-day EMA: | 37.75 | Buy |
ProShares Ultra Financials Earnings Growth & UYG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
ProShares Ultra Financials Technical Analysis
| May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||